Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer: overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
In breast cancer, the role of epigenetic alterations including modifications of the acetylation status of histones in carcinogenesis has been an important research focus during the last years. An increased deacetylation of histones leads to increased cell proliferation, cell migration, angiogenesis...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
30 April 2013
|
| In: |
BMC cancer
Year: 2013, Jahrgang: 13, Pages: 1-8 |
| ISSN: | 1471-2407 |
| DOI: | 10.1186/1471-2407-13-215 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-13-215
|
| Verfasserangaben: | Berit Maria Müller, Lisa Jana, Atsuko Kasajima, Annika Lehmann, Judith Prinzler, Jan Budczies, Klaus-Jürgen Winzer, Manfred Dietel, Wilko Weichert and Carsten Denkert |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1761018108 | ||
| 003 | DE-627 | ||
| 005 | 20230426153055.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210622s2013 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/1471-2407-13-215 |2 doi | |
| 035 | |a (DE-627)1761018108 | ||
| 035 | |a (DE-599)KXP1761018108 | ||
| 035 | |a (OCoLC)1341416877 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pfitzner, Berit Maria |d 1979- |e VerfasserIn |0 (DE-588)130009776 |0 (DE-627)487569318 |0 (DE-576)297948679 |4 aut | |
| 245 | 1 | 0 | |a Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer |b overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression |c Berit Maria Müller, Lisa Jana, Atsuko Kasajima, Annika Lehmann, Judith Prinzler, Jan Budczies, Klaus-Jürgen Winzer, Manfred Dietel, Wilko Weichert and Carsten Denkert |
| 246 | 3 | 0 | |a one two three |
| 264 | 1 | |c 30 April 2013 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 22.06.2021 | ||
| 520 | |a In breast cancer, the role of epigenetic alterations including modifications of the acetylation status of histones in carcinogenesis has been an important research focus during the last years. An increased deacetylation of histones leads to increased cell proliferation, cell migration, angiogenesis and invasion. Class 1 histone deacetylases (HDAC) seem to be most important during carcinogenesis. | ||
| 650 | 4 | |a Breast cancer | |
| 650 | 4 | |a HDAC | |
| 650 | 4 | |a Immunohistochemistry | |
| 700 | 1 | |a Jana, Lisa |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kasajima, Atsuko |e VerfasserIn |4 aut | |
| 700 | 1 | |a Lehmann, Annika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Prinzler, Judith |e VerfasserIn |4 aut | |
| 700 | 1 | |a Budczies, Jan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Winzer, Klaus-Jürgen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Dietel, Manfred |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weichert, Wilko |d 1970-2023 |e VerfasserIn |0 (DE-588)123509106 |0 (DE-627)56134650X |0 (DE-576)293740461 |4 aut | |
| 700 | 1 | |a Denkert, Carsten |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t BMC cancer |d London : BioMed Central, 2001 |g 13(2013), Artikel-ID 215, Seite 1-8 |h Online-Ressource |w (DE-627)326643710 |w (DE-600)2041352-X |w (DE-576)107014645 |x 1471-2407 |7 nnas |a Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression |
| 773 | 1 | 8 | |g volume:13 |g year:2013 |g elocationid:215 |g pages:1-8 |g extent:8 |a Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression |
| 856 | 4 | 0 | |u https://doi.org/10.1186/1471-2407-13-215 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210622 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 123509106 |a Weichert, Wilko |m 123509106:Weichert, Wilko |d 910000 |d 912000 |e 910000PW123509106 |e 912000PW123509106 |k 0/910000/ |k 1/910000/912000/ |p 9 | ||
| 999 | |a KXP-PPN1761018108 |e 3940712191 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"title":[{"title_sort":"Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer","subtitle":"overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression","title":"Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer"}],"name":{"displayForm":["Berit Maria Müller, Lisa Jana, Atsuko Kasajima, Annika Lehmann, Judith Prinzler, Jan Budczies, Klaus-Jürgen Winzer, Manfred Dietel, Wilko Weichert and Carsten Denkert"]},"person":[{"family":"Pfitzner","display":"Pfitzner, Berit Maria","given":"Berit Maria","role":"aut"},{"family":"Jana","display":"Jana, Lisa","role":"aut","given":"Lisa"},{"family":"Kasajima","given":"Atsuko","role":"aut","display":"Kasajima, Atsuko"},{"family":"Lehmann","display":"Lehmann, Annika","given":"Annika","role":"aut"},{"family":"Prinzler","role":"aut","given":"Judith","display":"Prinzler, Judith"},{"display":"Budczies, Jan","given":"Jan","role":"aut","family":"Budczies"},{"given":"Klaus-Jürgen","role":"aut","display":"Winzer, Klaus-Jürgen","family":"Winzer"},{"family":"Dietel","display":"Dietel, Manfred","role":"aut","given":"Manfred"},{"family":"Weichert","given":"Wilko","role":"aut","display":"Weichert, Wilko"},{"given":"Carsten","role":"aut","display":"Denkert, Carsten","family":"Denkert"}],"recId":"1761018108","origin":[{"dateIssuedKey":"2013","dateIssuedDisp":"30 April 2013"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 22.06.2021"],"relHost":[{"pubHistory":["1.2001 -"],"language":["eng"],"part":{"volume":"13","text":"13(2013), Artikel-ID 215, Seite 1-8","year":"2013","pages":"1-8","extent":"8"},"title":[{"title_sort":"BMC cancer","title":"BMC cancer"}],"recId":"326643710","origin":[{"publisherPlace":"London ; Berlin ; Heidelberg","dateIssuedKey":"2001","publisher":"BioMed Central ; Springer","dateIssuedDisp":"2001-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 22.05.20"],"id":{"zdb":["2041352-X"],"issn":["1471-2407"],"eki":["326643710"]},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progressionBMC cancer"}],"id":{"eki":["1761018108"],"doi":["10.1186/1471-2407-13-215"]},"physDesc":[{"extent":"8 S."}]} | ||
| SRT | |a PFITZNERBEDIFFERENTI3020 | ||